title: Whole blood superoxide anion generation and efficiency of some erythrocyte antioxidant systems during recombinant human erythropoietin therapy of uremic anemia.
abstract: Six chronic uremic patients on regular hemodialysis treatment were given recombinant human erythropoietin (r-huEPO) in a dose of 50 U/kg of body weight intravenously thrice weekly for 14 weeks. Following r-huEPO therapy, unstimulated whole blood superoxide anion (O2) generation did not change significantly, while opsonized zymosan-stimulated whole blood O2 generation increased. At the same time, erythrocyte superoxide dismutase and, in particular, glutathione peroxidase activities were found to be reducing with concomitant lowering of erythrocyte malonyldialdehyde (MDA) concentrations and increase in plasma MDA concentrations.
authors.affiliation: 2nd Department of Internal Medicine, Institute of Internal Medicine, WAM, Lódź, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Luciak
authors.forename: L
authors.initials: L
authors.lastname: Pawlicki
authors.forename: J
authors.initials: J
authors.lastname: Kedziora
authors.forename: K
authors.initials: K
authors.lastname: Trznadel
authors.forename: J
authors.initials: J
authors.lastname: Błaszczyk
authors.forename: A
authors.initials: A
authors.lastname: Buczyński
mesh_terms: D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000097:blood* / Q000628:therapy; D000975:Antioxidants; D004912:Erythrocytes / Q000378:metabolism*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D013482:Superoxide Dismutase / Q000097:blood; D013481:Superoxides / Q000097:blood*; D014511:Uremia / Q000097:blood* / Q000628:therapy
chemical_list: D000975:Antioxidants; D011994:Recombinant Proteins; D013481:Superoxides; D004921:Erythropoietin; D013482:Superoxide Dismutase